CSPC Innovation Pharmaceutical Co Ltd Class A (300765) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.009x

Based on the latest financial reports, CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a cash flow conversion efficiency ratio of -0.009x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.98 Million ≈ $-3.80 Million USD) by net assets (CN¥2.80 Billion ≈ $409.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CSPC Innovation Pharmaceutical Co Ltd Cl (300765) defensive interval to measure how many days the company can operate on defensive assets alone.

CSPC Innovation Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how CSPC Innovation Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CSPC Innovation Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CSPC Innovation Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
White Mountains Insurance Group Ltd NYSE:WTM	0.028x
Macy’s Inc NYSE:M	0.243x
Sonoco Products Company NYSE:SON	-0.103x
Lantheus Holdings Inc NASDAQ:LNTH	0.083x
Murphy Oil Corporation NYSE:MUR	0.061x
DEME Group NV BR:DEME	0.154x
Beijing New Building Materials Public Ltd Co SHE:000786	0.092x
Xinfengming Group Co Ltd SHG:603225	0.089x

Annual Cash Flow Conversion Efficiency for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual cash flow conversion efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see CSPC Innovation Pharmaceutical Co Ltd Cl (300765) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.80 Billion ≈ $409.04 Million	CN¥-195.69 Million ≈ $-28.64 Million	-0.070x	+74.52%
2024-12-31	CN¥4.50 Billion ≈ $657.90 Million	CN¥-1.24 Billion ≈ $-180.73 Million	-0.275x	-262.45%
2023-12-31	CN¥5.48 Billion ≈ $802.37 Million	CN¥927.24 Million ≈ $135.68 Million	0.169x	+4.10%
2022-12-31	CN¥3.94 Billion ≈ $577.16 Million	CN¥640.72 Million ≈ $93.76 Million	0.162x	+83.40%
2021-12-31	CN¥3.30 Billion ≈ $482.55 Million	CN¥292.09 Million ≈ $42.74 Million	0.089x	-31.82%
2020-12-31	CN¥2.69 Billion ≈ $393.18 Million	CN¥349.07 Million ≈ $51.08 Million	0.130x	-0.51%
2019-12-31	CN¥2.42 Billion ≈ $353.44 Million	CN¥315.38 Million ≈ $46.15 Million	0.131x	-18.30%
2018-12-31	CN¥999.35 Million ≈ $146.24 Million	CN¥159.73 Million ≈ $23.37 Million	0.160x	+9327.66%
2017-12-31	CN¥766.93 Million ≈ $112.23 Million	CN¥1.30 Million ≈ $190.26K	0.002x	-99.29%
2016-12-31	CN¥572.02 Million ≈ $83.70 Million	CN¥137.27 Million ≈ $20.09 Million	0.240x	+34.25%
2015-12-31	CN¥626.83 Million ≈ $91.72 Million	CN¥112.05 Million ≈ $16.40 Million	0.179x	+2.85%
2014-12-31	CN¥537.16 Million ≈ $78.60 Million	CN¥93.36 Million ≈ $13.66 Million	0.174x	--

About CSPC Innovation Pharmaceutical Co Ltd Class A

SHE:300765 China Packaged Foods

Market Cap

$4.92 Billion

CN¥33.64 Billion CNY

Market Cap Rank

#3658 Global

#545 in China

Share Price

CN¥23.95

Change (1 day)

-2.60%

52-Week Range

CN¥23.23 - CN¥58.32

All Time High

CN¥189977.21